These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 19383082

  • 21. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.
    Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G.
    Hepatogastroenterology; 2000 May 15; 47(36):1654-8. PubMed ID: 11149026
    [Abstract] [Full Text] [Related]

  • 24. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
    Giannini E, Arzani L, Borro P, Botta F, Fasoli A, Risso D, Celle G, Testa R.
    Hepatogastroenterology; 2000 May 15; 47(35):1395-8. PubMed ID: 11100360
    [Abstract] [Full Text] [Related]

  • 25. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
    Chalasani N, Said A, Ness R, Hoen H, Lumeng L.
    Am J Gastroenterol; 1999 Aug 15; 94(8):2224-9. PubMed ID: 10445554
    [Abstract] [Full Text] [Related]

  • 26. Hepatocellular carcinoma: epidemiology, risk factors, and screening.
    Sherman M.
    Semin Liver Dis; 2005 Aug 15; 25(2):143-54. PubMed ID: 15918143
    [Abstract] [Full Text] [Related]

  • 27. Surveillance for hepatocellular carcinoma.
    Della Corte C, Colombo M.
    Semin Oncol; 2012 Aug 15; 39(4):384-98. PubMed ID: 22846857
    [Abstract] [Full Text] [Related]

  • 28. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients.
    Sangmala P, Chaikledkaew U, Tanwandee T, Pongchareonsuk P.
    Asian Pac J Cancer Prev; 2014 Aug 15; 15(20):8993-9004. PubMed ID: 25374242
    [Abstract] [Full Text] [Related]

  • 29. Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma.
    Wang Q, Luan W, Villanueva GA, Rahbari NN, Yee HT, Manizate F, Hiotis SP.
    J Dig Dis; 2012 Apr 15; 13(4):214-8. PubMed ID: 22435506
    [Abstract] [Full Text] [Related]

  • 30. [Early diagnosis of hepatocarcinoma: criteria for the performance of screening in patients with liver cirrhosis].
    Cristani A, Cioni G, Vignoli A, Zerbinati F, Ventura P, Tincani E, De Santis M, Ventura E.
    Recenti Prog Med; 1991 Apr 15; 82(7-8):394-6. PubMed ID: 1658881
    [Abstract] [Full Text] [Related]

  • 31. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
    Trinchet JC, Nahon P, Ganne-Carrie N.
    Rev Prat; 2013 Feb 15; 63(2):222-5. PubMed ID: 23513790
    [Abstract] [Full Text] [Related]

  • 32. Markers for hepatocellular carcinoma.
    Wu AH, Sell S.
    Immunol Ser; 1990 Feb 15; 53():403-22. PubMed ID: 1713067
    [Abstract] [Full Text] [Related]

  • 33. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
    García-Samaniego J, Rodríguez M, Berenguer J, Rodríguez-Rosado R, Carbó J, Asensi V, Soriano V.
    Am J Gastroenterol; 2001 Jan 15; 96(1):179-83. PubMed ID: 11197250
    [Abstract] [Full Text] [Related]

  • 34. A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
    Hsu SX, Siegel AB, Berk PD.
    Semin Liver Dis; 2010 Feb 15; 30(1):99-106. PubMed ID: 20175037
    [Abstract] [Full Text] [Related]

  • 35. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
    Liaw YF.
    Semin Liver Dis; 2005 Feb 15; 25 Suppl 1():40-7. PubMed ID: 16103980
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
    Sherman M.
    Semin Liver Dis; 2010 Feb 15; 30(1):3-16. PubMed ID: 20175029
    [Abstract] [Full Text] [Related]

  • 38. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.
    Tangutur NK, Medvedev SF, Regenstein F, Balart LA.
    J La State Med Soc; 2011 Feb 15; 163(4):185-90. PubMed ID: 21954650
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.
    Nguyen VT, Razali K, Amin J, Law MG, Dore GJ.
    J Gastroenterol Hepatol; 2008 Jun 15; 23(6):922-9. PubMed ID: 17608637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.